[en] The capability of neonates to achieve cytokine balance was evaluated. Production of the pro-inflammatory cytokines TNF alpha and IL-8, of the natural anti-inflammatory cytokine IL10 and of the regulator of the acute phase response IL6 was assessed after whole blood stimulation by lipopolysaccharide in cord blood (n = 10), adult volunteers serving as control (n = 17). Additionally, circulating cytokines were determined in cord and in maternal blood immediately after delivery (n = 27, respectively). Significant production of TNF alpha, IL8, IL10 and IL6 was observed in cord blood after lipopolysaccharide stimulation and was similar to cytokine production in adult blood. The plasma concentrations of TNF alpha were significantly higher in cord than in maternal blood, while plasma concentrations of IL10 and IL6 were significantly lower. Our results demonstrate fully developed capability of whole cord blood to synthesize pro- and anti-inflammatory cytokines in response to a pro-inflammatory stimulation in vitro. In vivo, however, higher circulating TNF alpha and lower IL10 and IL6 levels in cord blood suggest that the inflammatory stress associated with normal delivery does not induce detectable anti-inflammatory response in neonates at birth.
Gaur S, Kesarwala H, Gavai M, Gupta M, Whitley-Williams P, Frenkel LD: Clinical immunology and infectious diseases, Pediatr Clin N Am 1994;41:745-782.
Seghaye MC, Duchateau J, Grabitz RG, Nitsch G, Marcus C, Messmer BJ, von Bernuth G: Complement, leukocytes, and leukocyte elastase in full-term neonates undergoing cardiac operation. J Thorac Cardiovasc Surg 1994;108:29-36.
Bruce MC, Baley JE, Medvik KA, Berger M: Impaired surface membrane expression of C3bi but not C3b receptors on neonatal neutrophils. Pediatr Res 1987;21:306-311.
Berger M: Complement deficiency and neutrophil dysfunction as risk factors for bacterial infection in newborns and the role of granulocyte transfusion in therapy. Rev Infect Dis 1990;12:3401-5409.
Pillay V, Savage N, Laburn H: Circulating cytokine concentrations and cytokine production by monocytes from newborn babies and adults. Pediatr Res 1994;428:197-201.
Schibler KR, Liechty KW, White WL, Rothstein G, Christensen RD: Defective production of interleukin-6 by monocytes: A possible mechanism underlying several host defence deficiencies of neonates. Pediatr Res 1992;31:18-21.
Liechty KW, Koenig JM, Mitchell MD, Romero R, Christensen RD: Production of interleukin-6 by fetal and maternal cells in vivo during intraamniotic infection and in vitro after stimulation with interleukin-1. Pediatr Res 1991;29:1-4.
Weatherstone KB, Rich EA: Tumor necrosis factor/cachectin and interleukin-1 secretion by cord blood monocytes from premature and term neonates. Pediatr Res 1989;25: 342-346.
Yachie A, Takano N, Yokoi T, Kato K, Kasahara Y, Miyawaki T, Taniguchi N: The capability of neonatal leukocytes to produce IL-6 on stimulation assessed by whole blood culture. Pediatr Res 1990;27:227-233.
Seghaye MC, Duchateau J, Bruniaux J, Demontoux S, Bosson C, Serraf A, Lecronier G, Mokhfi E, Planché C: Interleukin-10 release related to cardiopulmonary bypass in infants undergoing cardiac operations. J Thorac Cardiovasc Surg 1996;111:545-553.
Tabardel Y, Duchateau J, Schmartz D, Marécaux G, Shahla M, Barvais L, Leclerc JL, Vincent JL; Corticosteroids increase blood Interleukin-10 levels during cardiopulmonary bypass in men. Surgery 1996;119: 76-80.
Chheda S, Palkowetz KH, Garofalo R, Rassin D, Goldman AS: Decreased interleukin-10 production by neonatal monocytes and T cells: Relationship to decreased production and expression of tumor necrosis factor-a and its receptors. Pediatr Res 1996;40:475-483.
Kotiranta-Ainamo A, Rautonen J, Rautonen N: Interleukin-10 production by cord blood mononuclear cells. Pediatr Res 1997;41:110-113.
De Groote D, Zangerle PF, Gevaert Y, Fassotte MF, Beguin Y, Noizat Pirenne F, Pirenne J, Gathy R, Lopez M, Dehart I. et aL: Direct stimulation of cytokines (IL-1 beta, TNF-alpha, IL-6, IL-2, IFN-gamma and GM-CSF) in whole blood. I. Comparison with isolated PBMC stimulation. Cytokine 1992;4:239-248.
Cassatella MA, Meda L, Bonora S, Ceska M, Constantin G: Interleukin 10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes: Evidence for an autocrine role of tumor necrosis factor and IL-1b in mediating the production of IL-8 triggered by lipopolysaccharide. J Exp Med 1993;178:2207-2211.
Cassatella MA: The production of cytokines by polymorphonuclear neutrophils. Immunol Today 1995; 16:21-26.
Darbonne WC, Rice GC, Mohter MA, Apple T, Hében CA, Valente AJ, Baker JB: Red blood cells are a sink for interleukin 8, a leukocyte chemotaxin. J Clin Invest 1991;88: 1362-1369.
Cohen L, Haziot A, Shen DR, Lin XY, Sia C, Harper R, Silver J, Goyert SM: CD14-independent responses to LPS require a serum factor that is absent from neonates. J Immunol 1995;155:5337-5342.
Chang M, Suen Y, Lee S, Baly D, Buzby JS, Knoppel E, Wolpe S, Cairo MS: Transforming growth factor-b1. macrophage inflammatory protein-1a, interleukin-8 gene expression is lower in stimulated human neonatal compared with adult mononuclear cells. Blood 1994; 84: 118-124.
Renninck D, Berg D, Holland G: Interleukin 10: An overview. Prog Growth Fact Res 1992;4:207-227.
Wanidworanum C, Strober W: Predominant role of tumor necrosis factor-a in human monocyte IL-10 synthesis. J Immunol 1993;151:6853-6851.
Cassatella MA, Meda L, Gasperini S, Calzetti F, Bonora S: Interleukin 10 (IL-10) upregulates IL-1 receptor antagonist production from lipopolysaccharide-stimulated human polymorphonuclear leukocytes by delaying mRNA degradation. J Exp Med 1994;179:1695-1699.
Hughes TK, Cadet P, Rady P, Tyring SK, Smith EM: Evidence for production and action of interleukin-10 in the pituitary. Cell Mol Neurobiol 1994;14:57-67.